Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04245189
Other study ID # AIG-G-EUSCP
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2021
Est. completion date December 31, 2021

Study information

Verified date January 2021
Source Asian Institute of Gastroenterology, India
Contact Mithun Sharma, MD
Phone 08790622655
Email drmithunsharma@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Alcohol is the common precipitating factor for both cirrhosis of liver as well as alcohol related chronic pancreatitis. However, in real life clinical setting, clinicians do not frequently see many cases of symptomatic pancreatitis in patients who present with features of cirrhosis of liver. On the contrary, in some patients presenting with alcohol related chronic pancreatitis, evidence of cirrhosis of liver is observed on imaging without other clinical features of cirrhosis.


Description:

The data on exact incidence of chronic pancreatitis in patients with alcoholic cirrhosis is scarce and there are no data to support or refute as to whether the incidence is same between alcoholic cirrhosis or cirrhosis due to any other cause. The co-existence of cirrhosis and chronic pancreatitis in alcoholics vary between 0.04 - 6%. However, till now no study has been conducted to evaluate the incidence of CP in patients with alcoholic cirrhosis of liver. In this study, the investigators propose to assess the incidence of chronic pancreatitis in patients of ethanol related cirrhosis of liver and compare the same with patients of cryptogenic liver cirrhosis and hepatitis B and C related liver cirrhosis. This would be one of the few studies till date, to use EUS as the diagnostic modality. The patients of cirrhosis would be categorized based on their Child Pugh criteria into three categories. All these patients would undergo EUS at the Institute and chronic pancreatitis screening would be considered positive if they fulfill the Rosemont criteria for chronic pancreatitis.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2021
Est. primary completion date October 1, 2021
Accepts healthy volunteers
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria: • Patients with diagnosis of ethanol related cirrhosis of liver who complains of central abdominal pain without any other identifiable cause of pain would be enrolled in the study. Exclusion Criteria: - Any patients with evidence of Hepatocellular carcinoma , autoimmune hepatitis related CLD, and PBC would be excluded. - Patients any co-existent other malignancy, sepsis, pregnancy. - An informed consent would be signed by the patient and any patient not willing to be a part of the study will be excluded.

Study Design


Intervention

Other:
Endoscopic ultrasound for detection of Chronic pancreatitis
Presence of Chronic pancreatitis in alcoholic cirrhosis patients.

Locations

Country Name City State
India Asian Institute of Gastroenterology Hospitals Hyderabad Telangana

Sponsors (1)

Lead Sponsor Collaborator
Asian Institute of Gastroenterology, India

Country where clinical trial is conducted

India, 

References & Publications (3)

Aparisi L, Sabater L, Del-Olmo J, Sastre J, Serra MA, Campello R, Bautista D, Wassel A, Rodrigo JM. Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects? World J Gastroenterol. 2008 Oct 28;14(40):6171-9. — View Citation

Catalano MF, Sahai A, Levy M, Romagnuolo J, Wiersema M, Brugge W, Freeman M, Yamao K, Canto M, Hernandez LV. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009 Jun;69(7):1251-61. doi: 10.1016/j.gie.2008.07.043. Epub 2009 Feb 24. — View Citation

Stevens T, Parsi MA. Endoscopic ultrasound for the diagnosis of chronic pancreatitis. World J Gastroenterol. 2010 Jun 21;16(23):2841-50. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of chronic pancreatitis in alcoholic cirrhotics as per Rosemont criteria . To assess the incidence of chronic pancreatitis in patients of ethanol related cirrhosis of liver and compare the same with patients of cryptogenic liver cirrhosis, hepatitis B and C related liver cirrhosis. 3 days
Secondary Assessment of Pain. Visual Analogue Scale (VAS) measures pain intensity based on observer assessment on a scale from 1 to 10, where higher values indicate more intense pain. 3 days
Secondary Pancreatic duct size. In patients found to have Chronic pancreatitis -Pancreatic duct size would be assessed. 3 days
See also
  Status Clinical Trial Phase
Recruiting NCT04106518 - Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
Completed NCT01065233 - Pangenomic Study During Alcoholic Cirrhosis
Recruiting NCT04250259 - SAMe Trial for Patients With Alcoholic Cirrhosis Phase 2
Active, not recruiting NCT01213927 - National Cohort of Uncomplicated Alcoholic Cirrhosis
Completed NCT00388323 - Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human N/A
Terminated NCT01342705 - Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis Phase 3
Recruiting NCT04689152 - Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis Phase 3
Recruiting NCT05155657 - Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells Phase 1
Terminated NCT03534141 - Mild Hypothermia and Acute Kidney Injury in Liver Transplantation N/A
Completed NCT02072746 - Zinc Supplementation in Alcoholic Cirrhosis N/A
Completed NCT00827723 - Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
Completed NCT01756794 - Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment N/A
Recruiting NCT05093881 - Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study N/A
Terminated NCT03508388 - Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis
Completed NCT02326103 - Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis Phase 0
Terminated NCT00188045 - Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients Phase 4
Withdrawn NCT04070508 - Early Detection of Alcoholic Liver Disease
Recruiting NCT04363424 - Alcohol Biomarker Study